日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Preclinical lentiviral hematopoietic stem cell gene therapy corrects Pompe disease-related muscle and neurological manifestations.

临床前慢病毒造血干细胞基因疗法可纠正庞贝病相关的肌肉和神经系统症状

Yoon John K, Schindler Jeffrey W, Loperfido Mariana, Baricordi Cristina, DeAndrade Mark P, Jacobs Mary E, Treleaven Christopher, Plasschaert Robert N, Yan Aimin, Barese Cecilia N, Dogan Yildirim, Chen Vicky Ping, Fiorini Claudia, Hull Fritz, Barbarossa Luigi, Unnisa Zeenath, Ivanov Daniel, Kutner Robert H, Guda Swaroopa, Oborski Christine, Maiwald Tim, Michaud Véronique, Rothe Michael, Schambach Axel, Pfeifer Richard, Mason Chris, Biasco Luca, van Til Niek P

DROSHA Knockout Leads to Enhancement of Viral Titers for Vectors Encoding miRNA-Adapted shRNAs

DROSHA基因敲除可提高编码miRNA适应性shRNA的载体的病毒滴度

Park, Hee Ho; Triboulet, Robinson; Bentler, Martin; Guda, Swaroopa; Du, Peng; Xu, Haiming; Gregory, Richard I; Brendel, Christian; Williams, David A

Lineage-specific BCL11A knockdown circumvents toxicities and reverses sickle phenotype

谱系特异性 BCL11A 敲低可避免毒性并逆转镰状细胞表型

Brendel, Christian; Guda, Swaroopa; Renella, Raffaele; Bauer, Daniel E; Canver, Matthew C; Kim, Young-Jo; Heeney, Matthew M; Klatt, Denise; Fogel, Jonathan; Milsom, Michael D; Orkin, Stuart H; Gregory, Richard I; Williams, David A